tiprankstipranks
CANbridge Pharmaceuticals Welcomes New Director
Company Announcements

CANbridge Pharmaceuticals Welcomes New Director

CANbridge Pharmaceuticals Inc. (HK:1228) has released an update.

Don't Miss our Black Friday Offers:

CANbridge Pharmaceuticals Inc. has announced the appointment of Dr. Fangxin Li as a non-executive Director and a member of the remuneration committee, effective September 30, 2024. Concurrently, Mr. Edward Hu will resign from his non-executive Director position and as a member of the same committee. The changes come as part of a board and committee reorganization to strengthen the company’s governance and strategic direction.

For further insights into HK:1228 stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App